Stockscreener 앱 받기
6.30
4.69%
-0.31
시간 외 거래:
6.22
-0.08
-1.27%
전일 마감가:
$6.61
열려 있는:
$6.65
하루 거래량:
834.30K
Relative Volume:
0.61
시가총액:
$407.52M
수익:
$202.09M
순이익/손실:
$-61.69M
주가수익비율:
-5.8333
EPS:
-1.08
순현금흐름:
$-35.64M
1주 성능:
+1.12%
1개월 성능:
-3.37%
6개월 성능:
-37.69%
1년 성능:
-63.90%
1일 변동 폭
$6.235
$6.66
1주일 범위
$5.91
$6.66
52주 변동 폭
$5.71
$17.49
Evolus Inc Stock (EOLS) Company Profile
명칭
Evolus Inc
전화
(949) 284-4555
주소
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
EOLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
6.30 | 412.05M | 202.09M | -61.69M | -35.64M | -1.08 |
|
ZTS
Zoetis Inc
|
143.26 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.88 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.20 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.63 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 다운그레이드 | Needham | Buy → Hold |
| 2025-04-17 | 개시 | BTIG Research | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-06-23 | 개시 | Needham | Buy |
| 2022-05-12 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-20 | 업그레이드 | Truist | Hold → Buy |
| 2021-05-06 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-04-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-24 | 다운그레이드 | Truist | Buy → Hold |
| 2020-07-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-02-06 | 재개 | Mizuho | Buy |
| 2019-11-26 | 개시 | SVB Leerink | Outperform |
| 2019-09-05 | 재개 | Mizuho | Buy |
| 2019-06-28 | 개시 | Wells Fargo | Market Perform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2019-01-29 | 개시 | Stifel | Buy |
모두보기
Evolus Inc 주식(EOLS)의 최신 뉴스
Will Evolus Inc. rebound enough to break evenMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Using economic indicators to assess Evolus Inc. potential2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
What machine learning models say about Evolus Inc.Earnings Risk Report & Safe Entry Zone Identification - newser.com
How to build a custom watchlist for Evolus Inc.Weekly Investment Recap & Entry Point Confirmation Signals - newser.com
Evolus Inc. stock trend forecastJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Equities Analysts Offer Predictions for Evolus Q3 Earnings - MarketBeat
What institutional flow reveals about Evolus Inc.2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Real time alert setup for Evolus Inc. performanceRisk Management & Weekly Chart Analysis and Guides - newser.com
Volume spikes in Evolus Inc. stock – what they meanJuly 2025 Macro Moves & Stepwise Trade Signal Implementation - newser.com
Is Evolus Inc. trending in predictive chart models2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Can Evolus Inc. recover in the next quarterGDP Growth & AI Forecast Swing Trade Picks - newser.com
Evolus Inc. stock daily chart insightsMarket Growth Review & AI Driven Price Forecasts - newser.com
Using portfolio simulators with Evolus Inc. included2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Is Evolus Inc. (EVL) stock good for wealth creationMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Jeffrey Plumer: Adding to the Legal Toolkit - Orange County Business Journal
Will Evolus Inc. (EVL) stock split increase liquidityWeekly Stock Report & Real-Time Sentiment Analysis - newser.com
Analyzing QuidelOrtho (NASDAQ:QDEL) and Evolus (NASDAQ:EOLS) - Defense World
Is Evolus Inc. meeting your algorithmic filter criteria2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Evolus, Inc. (NASDAQ:EOLS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Price momentum metrics for Evolus Inc. explainedMarket Growth Review & AI Driven Stock Reports - newser.com
What analysts say about Evolus Inc stockStock Buyback Announcements & Capitalize On Momentum - earlytimes.in
Is Evolus Inc. (EVL) stock a buy for dividend portfoliosWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Midday Stock Roundup: Clean Energy Fuels Corp. Up Nearly 6% - Orange County Business Journal
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $19 - 富途牛牛
Assenagon Asset Management S.A. Sells 98,325 Shares of Evolus, Inc. $EOLS - MarketBeat
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consu - GuruFocus
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch - Nasdaq
Revolutionary Cold-X Technology: Evolus Partners with Top Miami Surgeon for Groundbreaking Filler Launch - Stock Titan
Evolus, Inc. $EOLS Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Risks Report: Whats the beta of Evolus Inc stockTrade Analysis Report & Real-Time Market Sentiment Alerts - خودرو بانک
Returns Recap: Is Evolus Inc a strong candidate for buy and holdTrade Volume Summary & Safe Capital Allocation Plans - khodrobank.com
While shareholders of Evolus (NASDAQ:EOLS) are in the black over 5 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Highs Report: What are Evolus Inc.’s earnings expectationsEarnings Miss & Verified Short-Term Trading Plans - خودرو بانک
Growth Recap: How does Evolus Inc. correlate with NasdaqJuly 2025 Volume & Capital Protection Trade Alerts - خودرو بانک
Volume Report: What analysts say about Flag Ship Acquisition Corporation stockQuarterly Risk Review & Short-Term Swing Trade Alerts - khodrobank.com
Downgrade Watch: What is the earnings history of Evolus IncWeekly Market Report & Growth Focused Investment Plans - khodrobank.com
Merger Talk: What analysts say about Evolus Inc stockMarket Volume Summary & Low Risk High Win Rate Stock Picks - khodrobank.com
Quarterly Trades: What hedge funds are buying Evolus IncExit Point & Technical Buy Zone Confirmations - خودرو بانک
Analyst Calls: Is Evolus Inc undervalued by DCF analysis2025 Buyback Activity & Free Reliable Trade Execution Plans - khodrobank.com
Sentiment Watch: Is Evolus Inc. stock trending bullishDollar Strength & Breakout Confirmation Alerts - خودرو بانک
Treasury Yields: Is Evolus Inc showing insider buyingJuly 2025 Movers & Low Risk High Reward Trade Ideas - خودرو بانک
Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven? - simplywall.st
Evolus Inc (EOLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Evolus Inc 주식 (EOLS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stewart Brady | Director |
Aug 15 '25 |
Buy |
6.82 |
30,000 |
204,486 |
88,629 |
| MOATAZEDI DAVID | See Remarks |
Jun 13 '25 |
Sale |
10.05 |
111,323 |
1,119,141 |
381,509 |
| MOATAZEDI DAVID | See Remarks |
Jun 16 '25 |
Sale |
9.89 |
16,582 |
164,054 |
364,927 |
0.05%
5.75%
자본화:
|
볼륨(24시간):